IP Library › Assignment 070384/0082
Patent Assignment
Reel/Frame 070384/0082

Assignment of Assignor's Interest

Recorded: 2025-03-03 Pages: 10
Assignor
LUNG THERAPEUTICS, LLC
Executed: 2025-02-28
Assignee
REIN THERAPEUTICS, INC.
12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TEXAS, 78758
Covered Properties (36)
Modified Peptide Fragments of Cav-1 Protein and the Use Thereof in the Treatment of Fibrosis
Application: 62/728,997 →
Modified Peptide Fragments of Cav-1 Protein and the Use Thereof in the Treatment of Fibrosis
Application: 17/274,721 →
Publication: US 2021/0347820
Modified Peptide Fragments of Cav-1 Protein and the Use Thereof in the Treatment of Fibrosis
Application: 18/069,541 →
Publication: US 2023/0212223
Modified Peptide Fragments of Cav-1 Protein and the Use Thereof in the Treatment of Fibrosis
Application: 18/460,215 →
Publication: US 2024/0018186
Epithelial Sodium Channel (Enac) Inhibitor Conjugates and Methods for Use Thereof
Application: 63/219,488 →
Epithelial Sodium Channel (Enac) Inhibitor Conjugates and Methods for Use Thereof
Application: 63/243,629 →
Epithelial Sodium Channel (Enac) Inhibitor Conjugates and Methods for Use Thereof
Application: 18/577,028 →
Publication: US 2024/0374585
Compositions and Methods for Protecting Type 2 Alveolar Epithelial Cells (AEC2)
Application: 62/816,374 →
Compositions and Methods for Protecting Type 2 Alveolar Epithelial Cells (AEC2)
Application: 62/874,760 →
Compositions and Methods for Protecting Type 2 Alveolar Epithelial Cells (AEC2)
Application: 17/437,952 →
Publication: US 2022/0160814
Modified Peptide Fragments of Cav-1 Protein and the Use Thereof
Application: 63/013,392 →
Modified Peptide Fragments of Cav-1 Protein and the Use Thereof
Application: 63/041,629 →
Modified Peptide Fragments of Cav-1 Protein and Uses Thereof
Application: 17/920,517 →
Publication: US 2023/0159608
Polypeptides for the Treatment of Pathogen-Induced Lung Injury
Application: 63/041,396 →
Modified Caveolin-1 Peptides for the Treatment of Pathogen-Induced Lung Injury
Application: 18/002,420 →
Publication: US 2023/0226149
Biomarkers for the Treatment of Interstitial Lung Disease
Application: 63/153,565 →
Biomarkers for the Treatment of Interstitial Lung Disease
Application: 63/270,867 →
Biomarkers for the Treatment of Interstitial Lung Disease
Application: 18/547,931 →
Publication: US 2025/0076312
Modified Caveolin-1 Peptides for the Treatment of Post-Acute Covid-19
Application: 63/211,649 →
Modified Caveolin-1 Peptides for the Treatment of Post-Acute Covid-19
Application: 63/278,258 →
Modified Caveolin-1 Peptides for the Treatment of Post-Acute Covid-19
Application: 18/571,114 →
Publication: US 2025/0041383
Modified Caveolin-1 Peptides for the Treatment of Chronic Kidney Disease
Application: 63/270,852 →
Modified Caveolin-1 Peptides for the Treatment of Chronic Kidney Disease
Application: 18/702,462 →
Publication: US 2025/0262273
Modified Caveolin-1 Peptide Formulations and Methods of Manufacturing and Use Thereof
Application: 63/368,169 →
Modified Caveolin-1 Peptide Formulations and Methods of Manufacturing and Use Thereof
Application: 18/993,188 →
Modified Caveolin-1 Peptide Formulations and Methods of Manufacturing and Use Thereof
Application: 63/504,901 →
Modified Peptide Fragments of Cav-1 Protein and the Use Thereof in the Treatment of Fibrosis
Epithelial Sodium Channel (Enac) Inhibitor Conjugates and Methods for Use Thereof
Compositions and Methods for Protecting Type 2 Alveolar Epithelial Cells (AEC2)
Modified Peptide Fragments of Cav-1 Protein and Uses Thereof
Modified Caveolin-1 Peptides for the Treatment of Pathogen-Induced Lung Injury
Biomarkers for the Treatment of Interstitial Lung Disease
Modified Caveolin-1 Peptides for the Treatment of Post-Acute Covid-19
Modified Caveolin-1 Peptides for the Treatment of Chronic Kidney Disease
Modified Caveolin-1 Peptide Formulations and Methods of Manufacturing and Use Thereof
Modified Caveolin-1 Peptide Formulations and Methods of Manufacturing and Use Thereof
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 10, 2019
From: CHRISTENSEN, DALE
To: LUNG THERAPEUTICS, INC.
Reel/Frame 049141/0988 →
Assignment of Assignor's Interest Mar 29, 2020
From: CHRISTENSEN, DALE; KOLENG, JOHN J.
To: LUNG THERAPEUTICS, INC.
Reel/Frame 052254/0062 →
Assignment of Assignor's Interest Oct 18, 2020
From: WINDSOR, BRIAN
To: LUNG THERAPEUTICS, INC.
Reel/Frame 054087/0695 →
Assignment of Assignor's Interest Oct 28, 2020
From: MACKENZIE, BREANNE; WINDSOR, BRIAN
To: LUNG THERAPEUTICS, INC.
Reel/Frame 054187/0539 →
Assignment of Assignor's Interest Nov 1, 2020
From: WINDSOR, BRIAN
To: LUNG THERAPEUTICS, INC.
Reel/Frame 054233/0713 →
Assignment of Assignor's Interest Mar 26, 2021
From: MACKENZIE, BREANNE
To: LUNG THERAPEUTICS, INC.
Reel/Frame 055735/0960 →
Assignment of Assignor's Interest Mar 26, 2021
From: HOGABOAM, CORY
To: LUNG THERAPEUTICS, INC.
Reel/Frame 055735/0971 →
Assignment of Assignor's Interest Jul 6, 2021
From: CHRISTENSEN, DALE; KOLENG, JOHN J.
To: LUNG THERAPEUTICS, INC.
Reel/Frame 056764/0013 →
Assignment of Assignor's Interest Aug 13, 2021
From: CHRISTENSEN, DALE J.
To: LUNG THERAPEUTICS, INC.
Reel/Frame 057171/0404 →
Assignment of Assignor's Interest Oct 29, 2021
From: CHRISTENSEN, DALE J.
To: LUNG THERAPEUTICS, INC.
Reel/Frame 057957/0834 →
Assignment of Assignor's Interest Oct 29, 2021
From: JUSTUS-LIEBIG UNIVERSITY OF GIESSEN
To: LUNG THERAPEUTICS, INC.
Reel/Frame 057957/0868 →
Assignment of Assignor's Interest Oct 29, 2021
From: WINDSOR, BRIAN
To: LUNG THERAPEUTICS, INC.
Reel/Frame 057959/0288 →
Assignment of Assignor's Interest Nov 2, 2021
From: MACKENZIE, BREANNE; HOGABOAM, CORY
To: LUNG THERAPEUTICS, INC.
Reel/Frame 057991/0481 →
Assignment of Assignor's Interest Nov 2, 2021
From: MACKENZIE, BREANNE; WINDSOR, BRIAN; HOGABOAM, CORY
To: LUNG THERAPEUTICS, INC.
Reel/Frame 057991/0336 →
Assignment of Assignor's Interest Nov 2, 2021
From: MACKENZIE, BREANNE; HOGABOAM, CORY; WINDSOR, BRIAN
To: LUNG THERAPEUTICS, INC.
Reel/Frame 057991/0528 →
Assignment of Assignor's Interest Nov 2, 2021
From: WINDSOR, BRIAN; MACKENZIE, BREANNE; HOGABOAM, CORY
To: LUNG THERAPEUTICS, INC.
Reel/Frame 057991/0513 →
Assignment of Assignor's Interest Nov 30, 2021
From: WINDSOR, BRIAN; MACKENZIE, BREANNE; HOGABOAM, CORY
To: LUNG THERAPEUTICS, INC.
Reel/Frame 058244/0810 →
Assignment of Assignor's Interest Dec 13, 2021
From: WINDSOR, BRIAN
To: LUNG THERAPEUTICS, INC.
Reel/Frame 058372/0572 →
Assignment of Assignor's Interest Aug 23, 2022
From: KOLENG, JOHN J.; WINDSOR, BRIAN; MACKENZIE, BREANNE; CHRISTENSEN, DALE J.
To: LUNG THERAPEUTICS, INC.
Reel/Frame 060873/0249 →
Assignment of Assignor's Interest Aug 29, 2022
From: MACKENZIE, BREANNE; HOGABOAM, CORY
To: LUNG THERAPEUTICS, INC.
Reel/Frame 060922/0250 →
Assignment of Assignor's Interest Oct 21, 2022
From: WINDSOR, BRIAN
To: LUNG THERAPEUTICS, INC.
Reel/Frame 061500/0787 →
Assignment of Assignor's Interest Dec 21, 2022
From: CHRISTENSEN, DALE; KOLENG, JOHN J.
To: LUNG THERAPEUTICS, INC.
Reel/Frame 062175/0627 →
Assignment of Assignor's Interest Feb 16, 2023
From: MACKENZIE, BREANNE; WINDSOR, BRIAN; HOGABOAM, CORY
To: LUNG THERAPEUTICS, INC.
Reel/Frame 062717/0542 →
Assignment of Assignor's Interest Jun 12, 2023
From: WINDSOR, BRIAN; MACKENZIE, BREANNE; CHRISTENSEN, DALE J.; KOLENG, JOHN J.
To: LUNG THERAPEUTICS, INC.
Reel/Frame 063921/0609 →
Assignment of Assignor's Interest Sep 8, 2023
From: CHRISTENSEN, DALE; KOLENG, JOHN J.
To: LUNG THERAPEUTICS, INC.
Reel/Frame 064839/0030 →